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Here we describe a system for promoterless analysis of putative internal ribosome entry site (IRES) elements using an alphavirus (family
Togaviridae) replicon vector. The system uses the alphavirus subgenomic promoter to produce transcripts that, when modified to contain a
spacer region upstream of an IRES element, allow analysis of cap-independent translation of genes of interest (GOI). If the IRES element is
removed, translation of the subgenomic transcript can be reduced >95% compared to the same transcript containing a functional IRES element.
Alphavirus replicons, used in this manner, offer an alternative to standard dicistronic DNA vectors or in vitro translation systems currently used to
analyze putative IRES elements. In addition, protein expression levels varied depending on the spacer element located upstream of each IRES. The
ability to modulate the level of expression from alphavirus vectors should extend the utility of these vectors in vaccine development.
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The study of IRES elements has traditionally been accom-
plished with systems that produce dicistronic RNAs. These
systems are usually plasmids that contain an RNA polymerase II
(pol II) promoter upstream of two reporter genes that are
separated by an IRES element (Macejak and Sarnow, 1991). The
pol II promoter is recognized by cellular RNA polymerase II that
then transcribes a capped mRNA. The 5′ reporter gene is
translated in a cap-dependent manner while the IRES element
upstream of the 3′ reporter gene initiates translation in a cap-
independent manner. A key to assigning IRES activity to any
sequence placed between the two reporter genes is dependent
upon the absence of a cryptic promoter or splice acceptor site
within the 5′ reporter gene or putative IRES element. The
presence of either of these can lead to the production of a second
transcript that contains the 3′ reporter gene in a configuration for
cap-dependent translation (Van Eden et al., 2004; Holcik et al.,
2005). Northern blot analysis is typically used to demonstrate
that only one transcript is produced from dicistronic plasmids.⁎ Corresponding author. Fax: +1 919 595 0402.
E-mail address: kamrud@alphavax.com (K.I. Kamrud).
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doi:10.1016/j.virol.2006.10.049Due to concerns that northern blot analysis is not sensitive
enough to detect the existence of low levels of transcript
produced by a cryptic promoter or splice acceptor site (Kozak,
2001b, 2003), promoterless dicistronic systems, RNAi-based
techniques andRT-PCR analysis have been employed to confirm
the activity of IRES elements (Han and Zhang, 2002). Dicis-
tronic plasmids modified to lack pol II DNA dependent RNA
promoters have also been used to determine whether any
promoter activity can be found associated with a putative IRES
element. In addition, in vitro transcribed RNA from the
promoterless dicistronic vector can be introduced into cultured
cells or used in in vitro translation reactions to monitor putative
IRES activity, thus obviating the nuclear aspects of transcription
(Han and Zhang, 2002).
Venezuelan equine encephalitis virus (VEE) is a member of
the Togaviridae family within the Alphavirus genus. Alpha-
viruses have a single-stranded positive-sense RNA genome of
approximately 11.4 kilobases (kb) in length. The genome is
capped at the 5′ end and polyadenylated at the 3′ end. The viral
nonstructural proteins (nsP1–nsP2–nsP3–nsP4) are encoded in
the 5′ two thirds of the genome, and the structural proteins
(capsid–E3–E2–6K–E1) are encoded in the 3′ one third of the
genome. The nonstructural proteins are translated in cells
Fig. 2. Luciferase and CAT expression analysis of dicistronic replicon vectors.
(A) Schematic representation of dicistronic replicon vectors. LUC, luciferase
gene; EV71, human enterovirus 71 IRES element; CAT, chloramphenicol
acetyl transferase gene; Black arrow, 26S subgenomic promoter; solid black
circle, 5′ cap structure; p(A), 3′ poly A sequence. (B) Results of luciferase and
CAT expression analysis represent the average activity detected from three
separate experiments. Error bars represent 1 standard deviation. RLU; relative
light units. CAT expression values were normalized based on luciferase
activity detected from each replicon. Neg. control; un-transfected Vero cell
lysates.
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proteins are translated from a subgenomic RNA that is
transcribed from a 26S promoter that is present on the full-
length negative-stranded RNA replication intermediate
(reviewed in Strauss and Strauss, 1994). Replication takes
place exclusively in the cytoplasm of cells. A number of
alphavirus expression systems have been developed by deleting
the structural protein coding region from the genome, thus
generating a self-replicating RNA or replicon vector (Breden-
beek et al., 1993; Liljestrom and Garoff, 1991; Pushko et al.,
1997; Xiong et al., 1989; Yamaguchi and Shirako, 2002).
Heterologous genes may be cloned downstream of the 26S
promoter in place of the structural protein genes. When the
replicon RNA is introduced into cells, the nonstructural proteins
are translated, which then replicate the viral RNA and express
the GOI cloned downstream of the 26S promoter to high levels.
The robust expression of GOIs is due to the high level
production of the subgenomic mRNA transcripts from the 26S
promoter. The cytoplasmic localization of alphavirus replication
and the ability of the replicon to produce subgenomic RNAs to
high levels led us to ask whether such a system could be used to
study the functional characteristics of IRES elements. Here we
describe an alphavirus replicon system developed to analyze
IRES activity that is not confounded by the possibility of either
cryptic DNA promoters or RNA splicing events and that offers
increased sensitivity over traditional dicistronic DNA vectors.
Results
Expression of CAT from dicistronic IRES replicon vectors
A number of approaches can be used to demonstrate that an
IRES element is responsible for programming cap-independent
translation of a gene. Three approaches are graphically depicted
in Fig. 1. One approach is to reverse the sequence of the
element, a second is to make a deletion in a critical stem loop
region and a third approach is to simply delete the putative IRES
element to inactivate the IRES in the context of a dicistronic
RNA (Fig. 1). After reversing, inactivating or deleting the IRES
in a dicistronic RNA, the absence or reduction of expression of
the second reporter gene, relative to the expression measured
from an active IRES, indicates that the IRES is controlling cap-
independent translation.Fig. 1. Schematic representation of dicistronic RNAs and modifications to the
IRES element used to demonstrate IRES control of translation. LUC; luciferase
gene, IRES; internal ribosome entry site, CAT; chloramphenicol acetyl
transferase.Dicistronic replicon vectors were constructed that produce a
subgenomic RNA coding for a 5′ reporter gene, luciferase
(LUC), separated from a 3′ reporter gene, chloramphenicol
acetyl transferase (CAT), by either a functional EV71 IRES or
an inactivated EV71 (ΔEV71) IRES element (Fig. 2A).
Dicistronic replicon RNAs were transcribed, electroporated
into Vero cells and both LUC and CAT expression were
analyzed. The average LUC and CAT activity determined from
three separate experiments is summarized in Fig. 2B. The
results indicate that the replicon vector coding for the dicistronic
RNAwith a functional IRES expressed both LUC protein (cap-
dependent) and CAT protein (cap-independent). These results
also demonstrate that the dicistronic replicon vector with the
inactivated IRES expressed CAT at only background levels
(Fig. 2B). Northern analysis, of total cellular RNA extracted
from the electroporated cells, using a CAT-specific probe
revealed that only the expected subgenomic RNA species was
detectable (Fig. 3), indicating that the CAT protein detected was
not being translated from unexpected RNA transcripts produced
by either dicistronic replicon vector. These data indicate that an
IRES element can control cap-independent translation of a
reporter gene in the context of a dicistronic subgenomic RNA
produced by an alphavirus replicon vector.
Fig. 3. Northern blot analysis of dicistronic replicon vectors. Total cellular RNA
was extracted from Vero cells electroporated with pERK/LUC/ΔEV71/CAT
dicistronic replicon RNA or pERK/LUC/EV71/CAT dicistronic replicon RNA
∼20 h post electroporation. The Northern blot was analyzed with CAT gene and
12S ribosomal RNA specific probes. Lane 1: pERK/LUC/ΔEV71/CAT, Lane 2:
pERK/LUC/EV71/CAT, Lane 3: RNA ladder.
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reporter gene
To determine whether insertion of sequences other than the
LUC gene upstream of the IRES would allow for specific cap-
independent translation to occur on a capped monocistronic
mRNA, additional replicons were constructed. Because the
optimal length and nucleotide sequence of the spacer region
were unknown, random DNA fragments were cloned between
the IRES sequence and the subgenomic promoter in the replicon
vectors. Fig. 4A shows a schematic of how the spacer-IRES-
CAT replicons were generated. To extend the preceding
dicistronic replicon analysis, pairs of replicon constructs
containing the same spacer sequence and either an EV71
(type I) or EMCV (type II) IRES sequence were generated. In
addition, null replicons were constructed that contained only the
spacer sequence and the CAT gene (Fig. 4A). If CAT expression
is cap-independent in the spacer-IRES replicons, there should be
little, if any CAT expression in the null replicons which lack an
IRES element.
To evaluate CAT expression levels, virus-like replicon
particles (VRP) were generated with each spacer-IRES-CAT
or null (spacer-CAT) replicon and used to infect Vero cells. The
average CAT activity determined from three separate experi-
ments is summarized in Fig. 4B. Protein expression was
quantified by CAT-specific ELISA, and subgenomic RNA
production was followed by Northern blot analysis using a
CAT gene-specific probe. Densitometric analysis of Northern
blots was also conducted using a probe specific for the 12S
ribosomal RNA to normalize the amount of RNA loaded in
each lane. The subgenomic RNA transcripts detected for each
null (spacer-CAT) replicon were set to a value of 1.0 and
compared to the subgenomic transcript amount from the
respective matching spacer-IRES-CAT replicons. An exampleof Northern blot analysis is shown in the lower portion of
Fig. 4B. In most instances, the relative amount of subgenomic
transcript for each null replicon was more than for the matched
spacer-IRES-CAT replicons (Fig. 4B). Even though the null
replicons produced robust amounts of subgenomic RNA
transcripts, very little CAT protein was detected by ELISA,
demonstrating that the spacer region inhibited cap-dependent
translation of the CAT reporter gene. In contrast, even though
fewer subgenomic transcripts were produced, each of the
spacer-IRES-CAT replicons expressed significant amounts of
CAT protein (Fig. 4B). These data indicate that the IRES
element in each spacer-IRES-CAT replicon efficiently pro-
grammed cap-independent translation.
Mouse immunization with different spacer-IRES replicons
As shown in Fig. 4B, the level of CAT expression from the
different IRES replicons, as determined in cell culture assays,
was dependent on the spacer element located upstream of each
IRES element. To determine whether in vitro expression levels
correlated with in vivo immunogenicity and efficacy, the
C-terminal portion of the heavy chain of botulinum neurotoxins
A and B (BoNT/HcA and BoNT/HcB, respectively) was cloned
into spacer-IRES replicons. The relative expression levels for the
BoNT/Hc proteins were determined for each spacer-IRES
replicon by densitometric analysis of Western blots probed
with BoNT/Hc specific antibodies and compared to the
expression level of the same genes expressed directly as a
subgenomic transcript without a spacer-IRES cassette. The
results of each comparison, normalized to the expression from
the non-spacer-IRES replicon, are shown in Table 1. Replicons
containing the EV71 IRES generally expressed the BoNT/Hc
genes at a higher level as compared to the replicons that did not
contain the spacer-IRES cassette. In contrast, replicons contain-
ing the EMCV IRES uniformly expressed at a lower level as
compared to a non-spacer-IRES replicon expressing the same
BoNT/Hc gene (Table 1).
Spacer IRES BoNT/Hc replicons, with different protein
expression profiles as determined in cell culture, were selected
and evaluated for immunogenicity and protective efficacy in a
murine BoNT challenge model. One EMCV and one EV71
spacer replicon were selected for both BoNT/HcA and BoNT/
HcB.
VRP were generated for each replicon, and mice were
immunized twice at a 4-week interval by two routes of admi-
nistration, subcutaneous (sc) and intramuscular (im). Serum
collected from the immunized animals was analyzed by
ELISA, and the mice were challenged 4 weeks after the
boost with 1000 LD50 of BoNT A or BoNT B. The results of
the ELISA analysis and protection from lethal BoNT challenge
are summarized in Table 2. Animals immunized with the
spacer-IRES BoNT/HcA replicon that showed the lowest level
of expression in cultured cells produced the lowest anti-BoNT
A antibody responses (a geometric mean titer (GMT) of ∼3
logs) and were only partially protected from challenge (Table
2). Only 1 of 10 subcutaneously inoculated mice and 4 of 10
intramuscularly inoculated mice survived challenge. However,
Fig. 4. CATexpression and Northern blot analysis of spacer-IRES-CATand null (spacer-CAT) replicon vectors. (A) Schematic representation of spacer-IRES-CATand
null replicons. Hatched box, inserted spacer fragment; IRES, either EV71 or EMCV element; CAT, chloramphenicol acetyl transferase gene; black arrow, 26S
subgenomic promoter; solid black circle, 5′ cap structure; p(A), 3′ poly A sequence. (B) CAT expression and Northern blot analysis of spacer-IRES-CAT and null
replicons. CATexpression results represent the average activity from three separate experiments. Error bars represent 1 standard deviation. Subgenomic transcript ratio
was determined by first normalizing the subgenomic transcripts using densitometry based on the cellular 12S ribosomal RNA signal. The normalized subgenomic
transcripts detected from null replicons were set to a value of 1.0 for comparison to spacer-matched IRES-replicons. The ratio of each spacer-IRES-CAT subgenomic
transcript relative to its spacer-matched null replicon is presented.
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that showed the highest level of expression in vitro produced
higher anti-BoNT A antibody responses (GMT ∼5 logs) and
were completely protected from challenge. In contrast, animals
vaccinated with either the low or high level expressing spacer-
IRES BoNT/HcB replicons produced similar immune
responses (GMT ∼5 logs) and were completely protected
from a lethal BoNT B challenge.
Discussion
Here we describe a system for examining the activity of
IRES elements using an alphavirus replicon vector. These
constructs make use of the alphavirus subgenomic promoter to
produce mRNA transcripts containing IRES elements that allow
for the analysis of cap-independent translation of a GOI.
Furthermore, the incorporation of spacer elements with IRESelements provides the ability to modulate protein expression
from the replicon system.
In addition to their use as expression and vaccine vectors,
these new alphavirus replicon vectors provide an attractive
alternative to the standard dicistronic DNA vectors or in vitro
translation systems currently used to analyze putative IRES
elements. The possible presence of either cryptic promoters or
splice acceptor sites present in putative IRES elements has
caused concern about the use of traditional dicistronic DNA
vectors (Han and Zhang, 2002; Kozak, 2001a,2001b; Liu
et al., 2005; Wang et al., 2005), and the replicon system offers
a way to eliminate such concerns for IRES analyses. Because
the replicon is RNA and does not have a DNA stage during
replication, there is no concern with respect to cryptic
promoters. In addition, replication of the replicon RNA occurs
entirely in the cytoplasm of cells therefore nuclear splicing
events cannot occur. Although in vitro translation systems and
Table 1
Relative expression levels for BoNT/Hc IRES replicons
BoNT/HcA replicons a
Spacer b 342 357 383 579 749 0
IRES EMCV EMCV EMCV EMCV EMCV No IRES
Normalized expression c 0.4 0.6 0.6 0.5 0.5 1.0
IRES EV71 EV71 EV71 EV71 EV71 No IRES
Normalized expression c 1.4 0.7 1.1 1.2 1.4 1.0
BoNT/HcB replicons a
Spacer b 342 357 383 579 749 0
IRES EMCV EMCV EMCV EMCV EMCV No IRES
Normalized expression c 0.7 0.6 0.5 0.6 0.4 1.0
IRES EV71 EV71 EV71 EV71 EV71 No IRES
Normalized expression c 0.7 1.4 1.3 0.8 1.1 1.0
a Cells electroporated with replicon RNAs were analyzed in parallel by IFA using a VEE anti-nsP2 specific antibody to ensure equivalent transfection efficiency
among the different constructs.
b Spacer fragment size in base pairs.
c BoNT/Hc-specific Western blot analysis and subsequent densitometric examination were carried out on protein lysates generated from electroporated cells. BoNT/
Hc expression from a replicon with no IRES or spacer was set at a value of 1.0. The BoNT/Hc expression detected from spacer IRES replicons is shown as relative
values compared to the BoNT/Hc expression detected from a replicon with no IRES or spacer present.
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culture can also obviate the concerns described above, the
sensitivity of these assays is limited by the amount of input
RNA (Han and Zhang, 2002; Thompson and Sarnow, 2003). It
has been reported that members of the Alphavirus genus
(Sindbis and Semliki Forest virus) activate protein kinases
involved in the cellular responses to stress factors (Ventoso et
al., 2006). Activation of these kinases catalyzes the phosphor-
ylation of eukaryotic initiation factor 2 alpha (eIF2α) which in
turn down-regulates cellular protein synthesis. It is possible
that alphavirus replication, by virtue of stimulating cellular
stress responses which down-regulate normal protein synth-
esis, may provide an excellent environment to detect IRES
activity. However, the replicon system may not be suited for
studying IRES elements if a non-stress cellular environment is
required.Table 2
Serological responses and protection of mice vaccinated with IRES BoNT/Hc replic
Vaccine a Relative expression level b R
342/EMCV/BoNT/Hc A Low s
342/EV71/BoNT/Hc A High s
342/EMCV/BoNT/Hc A Low i
342/EV71/BoNT/Hc A High i
Control (BoNT A challenge) e na f s
Control (BoNT A challenge) e na f i
342/EMCV/BoNT/Hc B Low s
357/EV71/BoNT/Hc B High s
342/EMCV/BoNT/Hc B Low i
357/EV71/BoNT/Hc B High i
Control (BoNT B challenge) e na f s
Control (BoNT B challenge) e na f i
a Animals were vaccinated twice with 107 IU of each VRP at 4-week intervals.
b Relative BoNT/Hc protein expression level was determined by Western blot ana
c Routes of immunization: sc, subcutaneous; im, intramuscular.
d GMT, reciprocal geometric mean titers just prior to BoNT challenge.
e Control groups received irrelevant VRP.
f na: not applicable.Subgenomic transcription from the 26S promoter amplifies
the number of transcripts containing the IRES sequence,
thereby increasing the chance of detecting IRES activity and
potentially allowing for the study of RNA–RNA or RNA–
protein interactions. Greater than 70,000 viral transcript copies
per cell have been detected in alphavirus infected cells (Powers
et al., 1996). The large number of transcripts containing the
IRES of interest should readily allow biochemical studies
involving association of initiation factors with IRES elements to
direct ribosome binding, as has been done with other IRES
elements (Holcik and Korneluk, 2000; Kieft et al., 2001; Kim
et al., 2001, 2003; Lomakin et al., 2000; Mitchell et al., 2001,
2003; Otto et al., 2002; Pestova et al., 1998; Pickering et al.,
2003; Spahn et al., 2001). In addition, concerns over the small
differences between background expression measured for the
negative control and putative IRES activity may be addressedons
oute of immunization c ELISA GMT d Survivor/total
c 11,143 1/10
c 409,600 10/10
m 8,445 4/10
m 382,170 10/10
c 129 0/5
m 49 0/5
c 89,144 10/10
c 89,144 10/10
m 102,400 10/10
m 95,543 10/10
c 84 0/5
m 48 0/5
lysis.
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large difference in expression between null (spacer-CAT)
replicons and spacer-IRES-CAT replicons demonstrated in
this report (>50-fold in several examples, Fig. 4B), it may be
possible to study IRES elements with weak activity. This
approach may also have particular utility in the study of putative
cellular IRES elements. Indeed, the stress environment created
by replication of the replicon RNA is not unlike the
environment in which many cellular IRES elements have
been identified (Cornelis et al., 2000; Pyronnet et al., 2000;
Coldwell et al., 2001). That is, most cellular IRES elements
have been identified under conditions where cap-dependent
translation has been interdicted. In addition, use of the replicon
system may eliminate spurious results due to cryptic promoters
and splice acceptors that have been shown to be present in some
previously described cellular IRES elements (Han et al., 2003;
Liu et al., 2005; Wang et al., 2005). Moreover, alphaviruses
replicate in many cell types, ranging from mammalian to insect
(Corsini et al., 1996). IRES containing replicon RNAs can be
introduced into these cell types either directly by electroporation
of the replicon RNA or by infection with VRP. In this way,
IRES function may be analyzed in a wide array of cell types that
were previously refractory due to the lack of cell type specific
DNA promoters to drive dicistronic vector transcription.
The presence of a spacer region upstream of an IRES
element on a subgenomic transcript resulted in a cap-
independent translation of the CAT reporter gene. The null
replicons (spacer-CAT) resulted in limited CAT expression via
cap-dependent translation, while replicons with spacer
sequences upstream of the IRES elements (spacer-IRES-CAT)
efficiently expressed CAT protein. Northern blot analysis
indicated that the robust expression from spacer-IRES-CAT
replicons was not due to production of a larger amount of
subgenomic transcripts. In fact, in most instances, the CAT
expression detected from spacer-IRES-CAT replicons was
translated from fewer transcripts than were present for the
matched null replicons. Although possible, it is unlikely that the
CAT expression detected in these experiments was the result of
translation off nicked replicon RNAs. The RNAs resulting from
a nicking event, that retain the CAT gene, would not be capped
and as a result would not be translated in a cap-dependent
manner. In addition, nicked RNAs would not be amplified
because they would lack the 5′ non-coding region required for
replication. Therefore, nicked RNAs would not be expected to
add any significant expression of CAT protein. To demonstrate
that little if any CAT expression results from translation of
replicon RNA that is not replicated, uncapped spacer-IRES
replicon RNAs were electroporated into Vero cells and CAT
protein expression was analyzed. No CAT expression was
detected by ELISA (data not shown). For these reasons, we
conclude that the CAT expression detected in these experiments
is due to subgenomic transcription of the replicon RNA rather
than spurious translation from nicked replicon RNAs.
Interestingly, replicons with the same IRES element but with
different spacer sequences expressed the GOI at different levels,
thus providing a newmechanism for controlling gene expression
from alphavirus vectors. One possible explanation for the rangeof expression may be that the spacer sequence influences (both
positively and negatively) the ability of the IRES elements to
recruit initiation factors by altering the secondary structure of the
IRES element itself. In addition, the sequence of a GOI may also
affect the function of an IRES element. This is suggested by the
results that showed that the same spacer-IRES combination did
not always result in the highest levels of expression for each gene
examined (i.e., the CAT, BoNT/Hc A and BoNT/Hc B genes).
Examples of mRNA secondary structure affecting translation
efficiency are well documented (Jaffrey et al., 1993; Kozak,
1986, 1990, 1991; Ray et al., 1983; Sonenberg, 1994). It is also
possible that the presence of upstream initiation codons (AUG)
in the spacer sequence may interfere with ribosome scanning
which in turn may enhance cap-independent translation via the
IRES element (Arrick et al., 1991; Kozak, 1989). The number of
AUG codons present in each spacer is as follows: 342 spacer
(6 AUG), 357 spacer (3 AUG), 383 spacer (4 AUG), 579 spacer
(9 AUG) and 749 spacer (16 AUG). The number of AUG codons
present in each spacer sequence did not uniformly predict the
expression level, but the 749 spacer-IRES replicons (containing
16 AUG codons) did express higher levels of those genes
examined here. It is likely that the combination of secondary
structure and the presence of initiation codons in each spacer
sequence results in the different expression levels demonstrated
in these studies. Analysis of predicted secondary structure for
each spacer-IRES-GOI combination may help optimize each
combination for efficient cap-independent translation.
The VEE replicon system has been shown to be an effective
means of immunizing animals against a wide variety of antigens
(Balasuriya et al., 2000, 2002; Davis et al., 2000; Hevey et al.,
1998; Lee et al., 2001, 2002, 2003; Pushko et al., 2001; Wilson
et al., 2001; Wilson and Hart, 2001). Upon inoculation, VRP
infection of cells leads to efficient expression of the antigenic
protein. VRP have also been shown to target antigen-presenting
dendritic cells (MacDonald and Johnston, 2000) and are capable
of inducing a broad array of Th-1-biased immune responses to
the encoded gene product, including cytotoxic T lymphocytes
(CTL), lymphoproliferative responses, and neutralizing and
protective antibody responses (Balasuriya et al., 2002; Davis et
al., 2000; Hevey et al., 1998; Lee et al., 2001, 2002, 2003;
Nelson et al., 2003; Pushko et al., 2001; Wilson et al., 2001;
Wilson and Hart, 2001). The high protein expression levels
attained with alphavirus replicon systems are thought to
contribute to its effectiveness (Liljestrom and Garoff, 1991;
Pushko et al., 1997). Other groups have shown, using DNA
expression systems, that increasing the level of antigen
expression can increase the immunogenicity of that antigen in
animal models (Deml et al., 2001; Ko et al., 2005; Narum et al.,
2001; Qiu et al., 1999; Sasaki et al., 2004; Stratford et al., 2000;
zur Megede et al., 2000). Utilizing the various spacer-IRES
replicons that express the GOI at different levels, we were able
to address a similar question. When animals were immunized
with a low-expressing BoNT/HcA replicon (as measured by
expression in Vero cells), the vaccine elicited lower ELISA
responses and only 5 out of 20 animals were protected from a
lethal BoNT A challenge. However, animals immunized with
the high-expressing BoNT/HcA replicon were completely
382 K.I. Kamrud et al. / Virology 360 (2007) 376–387protected against a similar challenge. In contrast, both the low
and the high expressing BoNT/HcB replicons provided
complete protection to the inoculated animals and stimulated
similar antibody responses in those animals, perhaps due to
inherent immunogenicity differences among these two
expressed products. However, it is clear that, depending on
the antigen tested, relatively small differences in in vitro
expression level may result in large differences in the immune
response observed in vivo. Selecting a BoNT/HcA replicon
with an intermediate expression level from the two examined in
this study may allow insight into the minimum amount of
expression required to impart a completely protective BoNT A
immune response in mice.
There are a number of advantages to having the ability to
control the level of protein expression from a replicon vector.
First, as indicated above for BoNT/HcA, higher expression
resulted in the stimulation of a more protective immune
response. Second, reduced expression could be advantageous
for the expression of genes where high levels of the expressed
products are toxic to cells or in which only low levels of
expressed protein are desirable, as in the co-expression of
immunomodulators. Because the gene of interest encoded in the
replicon vector is expressed in the cells initially used to produce
the VRP, low expression of a toxic gene may increase VRP
yields, and in these cases a compromise must be selected
between VRP yield and in vivo immune response desired.
Third, it may be advantageous to modify the expression of two
proteins from a single replicon or combine replicons that
express proteins at different levels to tailor an immune response
in the context of a multivalent vaccine.
In conclusion, we demonstrate that alphavirus replicon
vectors can be used to examine the cap-independent translation
imparted by both type I (EV71) and type II (EMCV) IRES
elements (Hellen and Sarnow, 2001; Thompson and Sarnow,
2003), and the RNA nature of alphavirus systems helps to
eliminate two frequent criticisms associated with IRES analyses
using dicistronic DNA vectors (i.e., the possibilities of cryptic
promoter and splice acceptor sites). In addition, the efficient
amplification of the replicon RNA during its cytoplasmic
replication allows for sensitive detection of cap-independent
translation. The combination of these two characteristics makes
the replicon system ideally suited to the study of putativeTable 3
List of PCR primers
Primer name
EMCVF (AscI).2
EMCVR (AscI).1
F′-CAT (BamHI)
R′-CAT (XbaI)
CAT-F (AscI)
CAT-R (AscI)
dc/MS (EcoRI) F
dc/MS (BamHI) R
ΔEV71-F
ΔEV71-R
luc BamR
luc PmeI Fcellular IRES elements. Furthermore, we have shown that the
use of an IRES in combination with varying spacer sequences
can alter the level of expression of that gene. The ability to
design alphavirus vectors that express GOI at varying levels
should allow selection of replicon-based vaccines that are both
immunogenic and produce efficient VRP yields in a manufac-
turing setting.
Materials and methods
Construction of transfer cloning vectors
A transfer vector (pCDNA3.3) was prepared for accepting
IRES and GOI sequences. Plasmid pCDNA3.1(+) (Invitrogen,
Carlsbad, CA) was digested with restriction enzyme BamHI
and treated with T4 DNA polymerase to create blunts ends that
eliminated the unique BamHI restriction site, resulting in
generation of pCDNA3.2. The pCDNA3.2 DNA was further
digested with restriction enzyme XbaI and also treated with T4
DNA polymerase to remove the unique XbaI restriction site,
resulting in generation of pCDNA3.3.
An intermediate cloning vector containing the multiple
cloning site (MCS) from a VEE replicon vector was prepared by
ligating an ∼250 bp ApaI/NotI MCS fragment into ApaI/NotI
linearized pBluescript KS+ (Stratagene, La Jolla, CA) DNA,
generating pKS-rep2. The EMCV IRES (a type II IRES
element) was digested from pD1+2+3 (Kaminski et al., 1995)
with restriction enzymes EcoRI and BamHI and ligated into
EcoRI and BamHI linearized pKS-rep2 DNA, generating
pKS-rep2/EMCV. The EMCV IRES and MCS sequence from
the pKS-rep2/EMCV vector was PCR amplified using primers
EMCVF (AscI).2 and EMCVR (AscI).1 (Table 3). The EMCV-
MCS PCR product was digested with AscI restriction enzyme
and ligated into AscI linearized VEE replicon (pERK) vector
DNA, generating pERK/EMCV. To complete the transfer
cloning vector, pERK/EMCV DNA was digested with EcoRV
and NotI restriction enzymes and the 862 bp EcoRV/NotI
fragment was isolated and then ligated into EcoRV and NotI
digested pCDNA3.3 DNA, generating pCDNA3.3/EMCV. The
sequence of the EMCV IRES and associated multiple cloning
sites was confirmed in the pCDNA3.3/EMCV vector before
preparing additional constructs.5′ primer sequence 3′
TGGCGCGCCGCTCGGAATTCCCCCTCTCCC
AGGCGCGCCTTCTATGTAAGCAGCTTGCC
GCTGGATCCATGGAGAAAAAAATCACTGGA
CGATCTAGATTACGCCCCGCCCTGCCACTCA
GGCGCGCCATGGAGAAAAAAATCACTGGA
GGCGCGCCTTACGCCCCGCCCTGCCACTCA
CGAATTCTTAAAACAGCTGTGGGTTG
CGGGATCCGGTCAACTGTATTGAGGGTTAATATAAAG
CCCAGTAACACCATGGAAGGGTGTTTCGCTCAGCACTTCCCCC
GGGTCATTCTCCTACCTTCCCACAAAGCGAGTCGTGAAGGGGG
TTTCGGATCCCAATCGCCGCGAGTTCTATGTAAGCAGC
GGGAAGTTTAAACATGGAAGACGCCAAAAACATAAAGAAAGG
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IRES element) (Thompson and Sarnow, 2003) was also cloned
into the pCDNA3.3 transfer vector. The EV71 IRES element
(strain 7423/MS/87) was PCR amplified from pdc/MS DNA
(Thompson and Sarnow, 2003) using primers dc/MS (EcoRI) F
and dc/MS (BamHI) R (Table 3). The EV71 IRES PCR
product was digested with EcoRI and BamHI restriction
enzymes and ligated into pCDNA3.3/EMCV digested with
EcoRI and BamHI to replace the EMCV sequence with the
EV71 sequence, generating pCDNA3.3/EV71. The EV71
IRES region, in pCDNA3.3/EV71, was sequenced to verify
that no nucleotide changes were introduced during the PCR
amplification.
Construction of inactivated IRES intermediate vectors
An inactivated EV71 IRES (ΔEV71) was produced by site
directed mutagenesis using primers ΔEV71-F and ΔEV71-R
(Table 3) and a QuikChange mutagenesis kit (Stratagene) to
delete five bases, from position 279 to position 283. The
pCDNA3.3/ΔEV71 vector was sequenced to confirm the
absence of the essential bases.
Construction of spacer-IRES replicon constructs
The CAT reporter gene was cloned into each of the
pCDNA3.3 transfer vectors. The CAT gene was amplified
using primers F′-CAT (BamHI) and R′-CAT (XbaI) (Table 3).
The PCR product was digested with BamHI and XbaI restriction
enzymes and ligated into BamHI and XbaI linearized
pCDNA3.3/EMCV, pCDNA3.3/EV71 and pCDNA3.3/
ΔEV71 plasmids. The following constructs were produced in
this manner pCDNA3.3/EMCV/CAT, pCDNA3.3/EV71/CAT
and pCDNA3.3/ΔEV71/CAT. The CAT gene was sequenced in
each construct to ensure that no errors had been introduced
during PCR amplification.
To generate a replicon vector with a functional EMCV/CAT
cassette downstream of the 26S promoter, pCDNA3.3/EMCV/
CAT DNAwas digested with AscI restriction enzyme to release
a 1303 bp EMCV/CAT fragment. The AscI digested EMCV/
CAT fragment was then ligated into AscI linearized pERK
vector DNA, generating pERK/EMCV/CAT. Random DNA
fragments were cloned between the EMCV IRES sequence and
the VEE subgenomic promoter at a unique EcoRV site located
in the pERK vectors (Fig. 4A). The random DNA fragments
cloned between the 26S promoter and the EMCV IRES were
generated by digesting pCDNA3.1(−) DNA (Invitrogen) with
AluI restriction enzyme. The AluI restriction enzyme cuts
frequently within the pCDNA3.1(−) plasmid resulting in blunt
ended fragments ranging in size from 6 bp to 706 bp. The AluI
digested pCDNA3.1(−) fragments were ligated into EcoRV
linearized pERK/EMCV/CAT. Individual clones were analyzed
by restriction analysis to demonstrate the presence of a spacer
sequence, and selected clones were sequenced to determine the
size of the spacer fragment in each new replicon vector.
Spacer replicon constructs containing the EV71 IRES were
produced by digesting the pCDNA3.3/EV71/CAT plasmid withAscI restriction enzyme and ligating the EV71/CAT AscI
fragments in place of the AscI fragment removed from the
pERK/EMCV/CAT spacer replicon vectors described above.
Null (spacer-CAT) replicons were constructed in two steps.
First the CAT gene was PCR amplified with CAT-F (AscI) and
CAT-R (AscI) primers (Table 3) and cloned into pCR2.1 TOPO
(Invitrogen), generating pCR2.1/CAT. The CAT gene was
sequenced to ensure that no errors were introduced during
amplification. To generate null replicons, each spacer replicon
was digested with AscI restriction enzyme to remove the IRES-
CAT fragment. The CAT gene was digested out of pCR2.1/CAT
with AscI restriction enzyme and ligated into each AscI
linearized spacer replicon. Restriction analysis was carried
out, and clones with the CAT gene in the correct orientation
were selected.
Construction of spacer-IRES BoNT/Hc replicon vectors
Human codon-optimized BoNTA/Hc and BoNT B/Hc genes
were synthesized (Blue Heron, Bothell, WA) and cloned into the
spacer replicons in two steps. First the genes were cloned into
transfer vector pCDNA3.3/EV71 or pCDNA3.3/EMCV. Each
gene was cloned as a BamHI/XbaI fragment into BamHI and
XbaI digested pCDNA3.3/EV71 or pCDNA3.3/EMCV DNA,
downstream of the IRES element, generating pCDNA3.3/
EV71/BoNT/HcA, pCDNA3.3/EV71/BoNT/HcB, pCDNA3.3/
EMCV/BoNT/HcA and pCDNA3.3/EMCV/BoNT/HcB
DNAs. The pCDNA3.3/BoNT/Hc plasmids were then digested
with AscI to release a IRES-BoNT/Hc-gene cassette. The IRES-
BoNT/Hc-gene AscI fragments were then ligated into AscI
linearized spacer replicons and the orientation of the inserts
determined by restriction analysis. Clones with BoNT/Hc-genes
in the sense orientation were selected and sequenced to ensure
that no errors were introduced during the cloning process.
Construction of dicistronic replicon vectors
Replicon constructs, with no spacer inserts, containing either
the EV71/CAT or ΔEV71/CAT cassettes were produced by
digesting the pCDNA3.3/EV71/CAT and pCDNA3.3/ΔEV71/
CAT plasmids with AscI restriction enzyme. The EV71/CAT
and ΔEV71/CAT AscI fragments were then ligated into AscI
linearized pERK DNA, generating pERK/EV71/CAT and
pERK/ΔEV71/CAT vectors. To generate dicistronic replicon
vectors that contain the LUC gene in the 5′ (cap-dependent)
position and the CAT gene in the 3′ (cap-independent) position,
the firefly luciferase (LUC) gene was PCR amplified from pdc/
MS DNA (Thompson and Sarnow, 2003) using PCR primers
luc BamR and luc PmeI F (Table 3). The PCR product was
digested with BamHI and then treated with T4 DNA polymerase
to produce a blunt end. The LUC gene was then further digested
with PmeI restriction enzymes and ligated into EcoRV
linearized pERK/EV71/CAT and pERK/ΔEV71/CAT DNAs.
The orientation of the LUC gene was determined by restriction
analysis, and clones with the LUC gene in the correct
orientation were selected, generating pERK/LUC/EV71/CAT
and pERK/LUC/ΔEV71/CAT dicistronic replicon vectors.
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Vero cells were maintained at 37 °C in an atmosphere
containing 5% CO2. The cells were grown in Minimum
Essential Medium (MEM; Invitrogen, Carlsbad, CA) supple-
mented with 5% fetal bovine serum (FBS, HyClone, Logan,
UT), MEM non-essential amino acid solution (Invitrogen) and
antibiotic–antimycotic (GIBCO). Capped replicon RNAs were
in vitro transcribed using a T7 RiboMax kit (Promega, Madison
WI) following the manufacturer's instructions, supplemented
with 7.5 mM CAP analog (Promega), from NotI linearized
replicon plasmid. RNAs were purified using RNEasy purifica-
tion columns (Qiagen, Valencia, CA) following the manufac-
turer's instructions. For replicon RNA only electroporation,
3×107 Vero cells suspended in PBS (GIBCO) were combined
with 30 μg of RNA in 0.2 cm cuvettes. The cells were pulsed 4
times using a BIO-RAD Gene Pulser (BIO-RAD, Hercules,
CA) with the instrument set at 290 V and 25 μF. After
electroporation, the cells were suspended in 35 ml of OptiPro
media (Invitrogen), 10 ml of each cell suspension was seeded
into 25 cm2 flasks and the flasks were incubated at 37 °C in 5%
CO2 for 16–24 h.
The procedures used for making VRP, based on a two helper
system as described in Pushko et al. (1997), are described in
detail in U.S. patent no. 7,078,218. Briefly, Vero cells (1×108
cells) suspended in PBS were combined with 30 μg of replicon
and each helper RNA in 0.4 cm electroporation cuvettes and
were electroporated using a BIO-RAD Gene Pulser (BIO-
RAD). The cells and RNA were pulsed four times with the
electroporator set at 580 V and 25 μF. Electroporated cell
suspensions were seeded into individual roller bottles contain-
ing 150 ml of OptiPro medium (Invitrogen) supplemented with
antibiotics and incubated at 37 °C in 5% CO2 for 16–24 h. VRP
were harvested and the titers of the VRP determined by
immunofluorescence assay (IFA) using goat anti-VEE nsP2
specific polyclonal antiserum as the primary antibody and
donkey anti-goat Alexa Fluor 488 (Invitrogen) as the secondary
antibody on methanol fixed cells using a Nikon Eclipse TE300
fluorescence microscope. The VRP were tested for the presence
of contaminating replication competent VEE (RCV) using two
blind passages on Vero cells. Briefly, 1×108 VRP were used to
infect Vero cells in 75 cm2 flasks (MOI=0.5) for 1 h. The VRP
inoculum was removed, the cell monolayers were washed with
PBS and 35 ml of fresh media was added to each flask. The
flasks were then incubated at 37 °C for 24 h. After incubation,
the pass 1 media was collected and used to inoculate fresh
75 cm2 flasks of Vero cells for 1 h. After the 1 h incubation, the
pass 1 media was removed, 35 ml of fresh media was added to
each flask and the flasks were incubated at 37 °C for an
additional 72 h. At the end of pass 2, the flasks were inspected
for the presence of cytopathic effects (CPE). The absence of
CPE in pass 2 flasks was deemed to indicate the absence of
RCV. The VRP titers are expressed as focus-forming units
(FFU) where one FFU is equivalent to one infectious unit (IU).
VRP were purified by affinity column chromatography using
Cellufine sulfate resin (Chisso Corporation, Tokyo, Japan) and
stored at −80 °C until used.Analysis of luciferase and CAT expression from dicistronic
replicon vectors
The expression of luciferase and CAT protein was analyzed
from dicistronic replicon vectors. Vero cells were electroporated
with 30 μg of replicon RNA (as described above). Luciferase
and CATexpression was quantified by luciferase assay and CAT
ELISA, using electroporated cell lysates and commercially
available Luciferase and CAT ELISA kits (Boehringer Man-
nheim, Indianapolis, IN) following the manufacturer's instruc-
tions. Luciferase activity was used to normalize the CAT
expression level between the two replicon vectors.
Analysis of CAT expression from IRES and null replicon
vectors
The expression of CAT protein from spacer-IRES-CAT
replicons and null (spacer-CAT) replicons was compared. Vero
cells were infected (MOI=3) with VRP generated with each
spacer-IRES-CAT or null (spacer-CAT) replicon. Cell lysates
were prepared ∼20 h post-infection, and CAT ELISA
(Boehringer Mannheim) analysis was carried out according to
the manufacturer's instructions. Total cellular RNA was
collected using an RNAwiz extraction kit (Ambion, Inc.,
Austin, TX) following the manufacturer's instructions from
cells infected in parallel with each VRP. Northern blot analysis
was carried out on each sample using probes specific for CAT
and 12S ribosomal RNAs. After chemiluminescent processing
of Northern blots, the densitometry function of the Labworks
Analysis Software associated with an Epi Chemi II Darkroom
(UVP) was used to quantitate the relative quantity of both
subgenomic CAT and 12S ribosomal RNA transcripts for each
sample.
BoNT Western blot analysis
For Western blot analysis, cells were lysed in TX100 lysis
buffer (10 mM Tris, 1 mM EDTA, 0.25 M NaCl, 1% Triton X-
100) for 10 min at 4 °C. After lysis, nuclei were removed by
microcentrifugation (12,000 RPM (12,800×g) for 10 min at
4 °C), and the total cell protein concentration for each sample
was determined using a BCA protein assay kit (Pierce,
Rockford, IL) according to the manufacturer's instructions.
Equal amounts of sample protein were combined with sodium
dodecyl sulfate (SDS) gel loading buffer and heated for 10 min
at 95 °C before electrophoresis through a 4–12% NuPAGE®
Bis–Tris polyacrylamide gel (Invitrogen). The separated
proteins were transferred to Immun-Blot PVDF membranes
(BIO-RAD) using an X-cell II blotting system and NuPage®
buffer (Invitrogen). Proteins were detected using goat antiserum
specific for BoNT/HcA and BoNT/HcB proteins, alkaline
phosphatase (AP)-conjugated anti-goat antibody (Sigma-
Aldrich, St. Louis, MO) and AP-specific color development
solution (BIO-RAD) for visualization. Relative amounts of
detected proteins were compared using the densitometry
function of the Labworks Analysis Software associated with
the Epi Chemi II Darkroom (UVP, Inc., Upland, CA).
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Mice were inoculated by the sc or im route with 107 IU of
each VRP diluted in 200 μl of PBS on day 0 and day 28 and
were challenged intraperitoneally on day 56 with 1000 median
lethal doses (MLD50) of BoNT diluted in 100 μl PBS containing
0.2% gelatin.
BoNT/Hc ELISA
The quantity of antibody present in the serum of vaccinated
animals just before challenge was measured by ELISA as
previously described (Lee et al., 2001). Briefly, microtiter plates
were coated with purified C. botulinum expressed BoNT
protein diluted in PBS. Titers for antibodies to BoNT are
defined as the reciprocal of the last dilution with an A405 of
≥0.1 after correction for background. Titers below 2.00 log10
and above 5.61 log10 were estimated. Serum from individual
animals was assayed in duplicate and used to calculate a
geometric mean titer for the group.
Northern blot analysis
Northern blot analysis was carried out on RNA isolated
from Vero cells after VRP infection or replicon RNA
electroporation. Total cellular RNA was isolated from the
Vero cells 20 h post electroporation or infection using an
RNAwiz extraction kit (Ambion, Inc., Austin, TX) following
the manufacturer's instructions. The RNAs were quantitated
using a UV/VIS spectrophotometer, and 2–3 μg of each RNA
was run on a 1% glyoxal agarose gel. The separated RNAs
were transferred to BrightStar-Plus membrane (Ambion) by
passive transfer using a TurboBlotter system (Whatman
Schleicher and Schuell, Florham Park, NJ) according to the
manufacturer's instructions. The nucleic acids were then UV
cross-linked to the membranes using a HL-2000 HybriLinker
(UVP Inc.). The membranes were blocked using UltraHyb
solution (Ambion) for 1 h at 68 °C and then probed overnight
with UltraHyb solution containing ∼100 ng of CAT and 12S
ribosomal RNA specific psoralen-biotin probes (Ambion) at
68 °C. The CAT and 12S ribosomal RNA specific psoralen-
biotin probes were generated according to the manufacturer's
instructions (Ambion). After overnight hybridization, the blot
was processed for chemiluminescent RNA detection using a
BrightStar BioDetect kit (Ambion) according to the manufac-
turer's instructions and visualized by exposing the blots to
film.
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